Declared Dividend • Jun 08
Dividend of CN¥1.16 announced Shareholders will receive a dividend of CN¥1.16. Ex-date: 10th June 2026 Payment date: 10th June 2026 Dividend yield will be 2.5%, which is higher than the industry average of 1.9%. Sustainability & Growth Dividend is covered by earnings (59% earnings payout ratio) but not covered by cash flows (281% cash payout ratio). The dividend has increased by an average of 1.8% per year over the past 3 years and payments have been stable during that time. EPS is expected to grow by 32% over the next year, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Apr 24
Full year 2025 earnings: Revenues and EPS in line with analyst expectations Full year 2025 results: EPS: CN¥1.75 (up from CN¥1.32 in FY 2024). Revenue: CN¥1.32b (up 20% from FY 2024). Net income: CN¥151.7m (up 29% from FY 2024). Profit margin: 12% (in line with FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Pharmaceuticals industry in China. Over the last 3 years on average, earnings per share has fallen by 11% per year whereas the company’s share price has fallen by 16% per year. Announcement • Apr 23
Bide Pharmatech Co., Ltd., Annual General Meeting, May 13, 2026 Bide Pharmatech Co., Ltd., Annual General Meeting, May 13, 2026, at 09:30 China Standard Time. Location: 6F, Building 3, No. 999, Xiangyin Road, Yangpu District, Shanghai China